The exam must be less invasive than other diagnostic methods; the company wants to offer the product “as soon as possible”
Tokyo – Commercialization of a test to be detected Alzheimers from a simple blood test was approved in Japanannounced its manufacturer this Thursday 22, a rare advance in the fight against generalized neurodegenerative disease.
In a statement, Japanese company Sysmex Corporation said it wanted to launch the minimally invasive diagnostic test in the Japanese market “as soon as possible”. According to Sysmex, its system measures in just over a quarter of an hour the level of accumulation of beta-amyloid protein in the blood, one of the main biomarkers of Alzheimer’s disease.
Other methods of diagnosing Alzheimer’s disease are available, but they are often expensive and invasive, such as brain imaging and a lumbar puncture to extract cerebrospinal fluid (CSF), because it is crucial to detect Alzheimer’s as early as possible to try to slow it down the progression of the disease.
Other blood tests are under development in other parts of the world or are awaiting marketing approval. “Simple, affordable, noninvasive, and easily accessible diagnostic tools are urgently needed” to improve early detection of Alzheimer’s, says the US-based Alzheimer’s Association. United States of Americaon its website.
In the future, blood tests “will very likely revolutionize the diagnostic process for Alzheimer’s and all dementias,” according to the organization.
Alzheimer’s disease remains incurable to this day, but in November, additional clinical data confirmed the potential of a new drug, lecanemab, to significantly delay the cognitive decline of patients treated for 18 months.
More than 55 million people worldwide suffer from dementia, a number that is expected to rise to 130 million by 2050 as life expectancy increases, according to the World Health Organization (WHO)🇧🇷 Alzheimer’s disease accounts for 60-70 % of cases./AFP
🇧🇷The best content in your email for free. Choose your favorite Terra newsletter. Click here!
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
